# Viridian (VRDN) — Overview

VRDN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/vrdn

## Price

Last close $19.56 on Oct 15, 2026. 52-week range $13.30 – $33.78.

## Company profile

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $71.1M |
| Revenue (quarter) | $284,000.00 |
| Revenue growth (year over year) | 278.67% |
| Gross profit (trailing twelve months) | $71.1M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$387.0M |
| Net income (quarter) | −$127.1M |
| Net income growth (year over year) | -26.19% |
| Net margin | -544.06% |
| Return on equity | -65.74% |
| EPS (trailing twelve months) | −$3.40 |
| Book value per share | $4.98 |
| P/E (trailing twelve months) | — |
| Price to book | 3.3 |
| Debt to assets | 39.66% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Viridian (VRDN) profitable?

No. Viridian reported a net loss of $387.0M over the trailing twelve months.

### How much revenue does Viridian (VRDN) make?

Viridian generated $71.1M in revenue over the trailing twelve months, up 278.67% year over year.

### How do I buy stock in Viridian (VRDN)?

VRDN trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).